Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Defense + Military

    Nano-Bio Manufacturing Consortium

    By Global Biodefense StaffNovember 16, 2012
    Share
    Facebook LinkedIn Reddit Email

    The U.S. Air Force Research Laboratory (AFRL) is taking steps to establish a Nano-Bio Manufacturing Consortium (NBMC) of large and small companies, academia, federal laboratories, and defense acquisition centers to accelerate innovation in nano-bio manufacturing technologies. 

    The NBMC effort is intended to accelerate risk assessment and the development of mitigation approaches for critical nano-bio materials and fabrication innovations by developing common technology and manufacturing platforms through public-private partnerships. 

    A fully functioning NBMC will be established in two phases.  Phase 1 NBMC over the first 36 months will work to establish the most crucial public-private partnerships and coordinate their activity around a technical project that is driven by dual use commercial-military needs, and currently inhibited by high risk integration of nano-bio materials and manufacturing techniques.  

    Phase II NBMC will leverage these successes to expand membership and potentially establish physical facilities as appropriate for the evolution of the consortium to span both virtual and physical bridges. 

    A successful consortium will serve as a technical center of excellence, providing the infrastructure to support manufacturing enterprises at a prototype level that are relevant and scalable; and ensuring that the key capabilities for DoD needs is available. 

    The Air Force intends to award a Department of Defense Grant and Agreement Regulations (DoDGARS) based Cooperative Agreement to a not-for-profit organization to spearhead Phase I NBMC. The award ceiling is $4.4M, of which the government share is $2.2M plus up to an additional $2.2M of a desired 50/50 recipient cost share. 

    The effort is being developed under Broad Agency Announcement BAA-13-01-RQKD.

    BAA Nanotech
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleKey Patent Awarded for Synthetic Saponin Vaccine Adjuvant
    Next Article Canadian Study Shows Possible Airborne Transmission of Ebola

    Related Stories

    New Method Improves Quantification of Ricin in Complex Matrices

    September 20, 2023

    Terrorism and the Pandemic: Weaponizing a Public Health Crisis

    September 20, 2023

    Mass Spec for Rapid Detection of Biological Warfare Agents

    September 15, 2023

    New Self-Decontaminating Fabric Burns Viruses, Safe for Skin

    September 14, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.